DOI QR코드

DOI QR Code

The Effectiveness of Ultrasound-Guided Thoracic Paravertebral Block for Percutaneous Radiofrequency Ablation of Hepatic Tumors: A Pilot Study

간종양의 경피적 고주파 열치료에서 초음파 유도하 흉부 방척추블록의 효용성: 예비 연구

  • Kim, Hyungtae (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Youngjun (Department of Radiology, Presbyterian Medical Center) ;
  • Kim, Beum Jin (Department of Radiology, Presbyterian Medical Center) ;
  • Shin, Sung In (Department of Anesthesiology and Pain Medicine, Presbyterian Medical Center) ;
  • Yim, So Mang (Department of Anesthesiology and Pain Medicine, Presbyterian Medical Center) ;
  • Lee, Ju-Hyung (Department of Preventive Medicine, Chonbuk National University Medical School)
  • 김형태 (울산대학교 의과대학 서울아산병원 마취통증의학교실) ;
  • 김영준 (예수병원 영상의학과) ;
  • 김범진 (예수병원 영상의학과) ;
  • 신성인 (예수병원 마취통증의학과) ;
  • 임소망 (예수병원 마취통증의학과) ;
  • 이주형 (전북대학교 의과대학 예방의학교실)
  • Received : 2018.05.09
  • Accepted : 2018.09.19
  • Published : 2018.12.01

Abstract

Purpose: The purpose of this study was to evaluate the effectiveness of thoracic paravertebral block (TPVB) for management of pain during and after percutaneous radiofrequency ablation (RFA) of hepatic tumor. Materials and Methods: All patients were divided into non-TPVB (4 patients, 4 sessions of RFA for 4 tumors) and TPVB group (5 patients, 7 sessions of RFAs for 7 tumors). Ultrasound (US)-guided TPVB was performed at T7 level. The 15 mL of 0.375% ropivacaine was injected into right paravertebral space before RFA. If patients complained pain and asked analgesics or experienced pain with verbal numerical rating scale (VNRS) of more than 4, fentanyl $25{\mu}g$ (up to $100{\mu}g$), pethidine 25 mg, and midazolam 0.05 mg/kg (up to 5 mg) were sequentially given intravenously during RFA. Results: Total intravenous morphine equivalence of analgesics before, during, and after RFA was 129.1 mg and 0.0 mg in non-TPVB and TPVB group, respectively. Conclusion: US-guided TPVB may be an effective and safe anesthetic method for decreasing or eliminating pain during and after RFA for hepatic tumor and helpful in decreasing the usage of opioids.

목적: 간종양의 경피적 고주파 열치료(radiofrequency ablation, 이하 RFA) 도중 및 종료 후 발생하는 통증을 관리하는데 있어 흉부방척추블록(thoracic paravertebral block, 이하 TPVB)의 효용성을 평가하고자 하였다. 대상과 방법: TPVB를 시행하지 않은 그룹(4명; 4개 종양, 4회 RFA)과 시행한 그룹(5명; 7개 종양, 7회 RFA)으로 나누었다. 초음파 유도하 TPVB는 7번 흉추에서 시행하였다. 시술 전 우측 방척추 공간에 0.375% ropivacaine을 15 mL 주입하였다. 시술 중 환자가 통증을 호소하며 진통제를 요구하거나 구두통증척도(verbal numerical rating scale) 4점 이상의 통증을 호소하면 fentanyl $25{\mu}g$ (최대 $100{\mu}g$), pethidine 25 mg, midazolam 0.05 mg/kg (최대 5 mg)을 순차적으로 정맥 주입하였다. 결과: RFA 전, 도중, 후 사용된 진통제의 총 정맥 주입 모르핀 등가(total intravenous morphine equivalence)는 TPVB를 시행하지 않은 그룹에서는 129.1 mg이었고, 시행한 그룹에서는 0.0 mg이었다. 결론: 초음파 유도하 TPVB는 간종양의 RFA 도중 및 후에 발생하는 통증을 감소시키는데 효과적이고 안전한 방법일 수 있겠으며 마약성 진통제의 사용량을 줄이는데 도움이 될 것이다.

Keywords

References

  1. Salhab M, Canelo R. An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis. J Cancer Res Ther 2011;7:463-475 https://doi.org/10.4103/0973-1482.92023
  2. Wu YZ, Li B, Wang T, Wang SJ, Zhou YM. Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis. World J Gastroenterol 2011; 17:4143-4148 https://doi.org/10.3748/wjg.v17.i36.4143
  3. Carrafiello G, Lagana D, Cotta E, Mangini M, Fontana F, Bandiera F, et al. Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience. Cardiovasc Intervent Radiol 2010;33:835-839 https://doi.org/10.1007/s00270-010-9849-3
  4. Yang W, Chen MH, Yin SS, Yan K, Gao W, Wang YB, et al. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early and late phase recurrence. AJR Am J Roentgenol 2006; 186(5 Suppl):S275-S283 https://doi.org/10.2214/AJR.04.1573
  5. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD, Dupuy DE, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005;235:728-739 https://doi.org/10.1148/radiol.2353042205
  6. Lee S, Rhim H, Kim YS, Choi D, Lee WJ, Lim HK, et al. Percutaneous radiofrequency ablation of hepatocellular carcinomas: factors related to intraprocedural and postprocedural pain. AJR Am J Roentgenol 2009;192:1064-1070 https://doi.org/10.2214/AJR.08.1350
  7. Park YR, Kim YS, Rhim H, Lim HK, Choi D, Lee WJ. Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression. AJR Am J Roentgenol 2009;193:757-763 https://doi.org/10.2214/AJR.08.2202
  8. Takaki H, Yamakado K, Sakurai H, Nakatsuka A, Shiraki K, Iasaji S, et al. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy. AJR Am J Roentgenol 2011;197:488-494 https://doi.org/10.2214/AJR.10.4933
  9. Kim YK, Kim CS, Chung GH, Han YM, Lee SY, Jin GY, et al. Radiofrequency ablation of hepatocellular carcinoma in patients with decompensated cirrhosis: evaluation of therapeutic efficacy and safety. AJR Am J Roentgenol 2006;186(5 Suppl):S261-S268 https://doi.org/10.2214/AJR.04.1266
  10. Shibata T, Shibata T, Maetani Y, Isoda H, Hiraoka M. Radiofrequency ablation for small hepatocellular carcinoma: prosepctive comparison of internally cooled electrode and expandable electrode. Radiology 2006;238:346-353 https://doi.org/10.1148/radiol.2381041848
  11. Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: a literature review. Int J Hepatol 2011;2011:104685
  12. Chen MH, Yang W, Yan K, Gao W, Dai Y, Wang YB, et al. Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol 2005;11:6395-6401 https://doi.org/10.3748/wjg.v11.i40.6395
  13. Richardson J, Lonnqvist PA. Thoracic paravertebral block. Br J Anaesth 1998;81:230-238 https://doi.org/10.1093/bja/81.2.230
  14. Korean Liver Cancer Study Group (KLCSG), National Cancer Center, Korea (NCC). 2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma. Gut Liver 2015;9:267-317
  15. Ripamonti C, Groff L, Brunelli C, Polastri D, Stavrakis A, De Conno F. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol 1998;16:3216-3221 https://doi.org/10.1200/JCO.1998.16.10.3216
  16. Mercadante S, Casuccio A, Fulfaro F, Groff L, Boffi R, Villari P, et al. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol 2001;19:2898-2904 https://doi.org/10.1200/JCO.2001.19.11.2898
  17. Karmakar MK. Thoracic paravertebral block. Anesthesiology 2001;95:771-780 https://doi.org/10.1097/00000542-200109000-00033
  18. Cheema SP, Ilsley D, Richardson J, Sabanathan S. A thermographic study of paravertebral analgesia. Anaesthesia 1995;50:118-121 https://doi.org/10.1111/j.1365-2044.1995.tb15092.x
  19. Lonnqvist PA, MacKenzie J, Soni AK, Conacher ID. Paravertebral blockade. Failure rate and complications. Anaesthesia 1995;50:813-815 https://doi.org/10.1111/j.1365-2044.1995.tb06148.x
  20. Cheung Ning M, Karmakar MK. Right thoracic paravertebral anaesthesia for percutaneous radiofrequency ablation of liver tumours. Br J Radiol 2011;84:785-789 https://doi.org/10.1259/bjr/28983063
  21. Gazzera C, Fonio P, Faletti R, Dotto MC, Gobbi F, Donadio P, et al. Role of paravertebral block anaesthesia during percutaneous transhepatic thermoablation. Radiol Med 2014;119:549-557 https://doi.org/10.1007/s11547-013-0372-x
  22. Piccioni F, Fumagalli L, Garbagnati F, Di Tolla G, Mazzaferro V, Langer M. Thoracic paravertebral anesthesia for percutaneous radiofrequency ablation of hepatic tumors. J Clin Anesth 2014;26:271-275 https://doi.org/10.1016/j.jclinane.2013.11.019
  23. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006;367:1618-1625 https://doi.org/10.1016/S0140-6736(06)68700-X
  24. Macrae WA. Chronic post-surgical pain: 10 years on. Br J Anaesth 2008;101:77-86 https://doi.org/10.1093/bja/aen099